Tarik Skubal returns for Detroit after elbow surgery, with positives despite rocky timing

Tarik Skubal is back in Detroit’s rotation after surgery sidelined him early, and while his return did not immediately look like a sharp, fully-formed version of the pitcher the Tigers have leaned on, there were signs that the process is moving in the right direction. Skubal, the franchise’s standard-bearer and a two-time reigning Cy Young winner, last pitched in the majors on April 29. According to CBS Sports, he returned to action on Saturday following a recovery period that had raised more questions than answers at various points in the spring and early summer.

The key development in Skubal’s comeback was the nature of the procedure performed on his left elbow. CBS reported that the surgery involved removing bone chips and that surgeons used a nanoscope as part of the operation. That level of instrumentation matters in these cases because it is designed to make the work smaller and more precise, potentially helping the healing process. The report also framed the recovery as faster than many around the game thought might be possible for a pitcher coming off elbow surgery.

Even with the calendar moving toward the heart of the season, the immediate reality of a return from an elbow procedure is that a pitcher’s feel, command, and pitch-shape often require additional time. CBS’s headline framing captures that tension, describing the return as “not his best,” even as it emphasized positives. In practical terms, it means Detroit gets its most consequential starting option back in the mix, but the club still has a reason to monitor workload, effectiveness, and overall performance trajectory rather than treat Saturday as a finish line.

For the Tigers, Skubal’s availability has implications that go beyond one start. As a two-time Cy Young winner, he represents the staff’s ceiling for run prevention and the anchor for any serious push, whether that push is defined internally by improving late-season positioning or externally by playoff-caliber expectations. When a top starter misses significant time, rotation depth, bullpen usage, and game planning all become more fragile, especially against high-end opponents that can force a longer outing or a strained pen.

There is also a market dimension to Skubal that Detroit cannot ignore. CBS described him as a potential trade candidate, which reflects the broader reality of MLB deadlines and the way elite pitchers often become the centerpiece of summer roster decisions. When an ace returns sooner than expected, it changes what teams can realistically ask for and how Detroit might approach any conversations about the future. Even if no deal is reached, having Skubal healthy enough to contribute limits the degree to which the Tigers must write off the rest of the season as a rebuild-only exercise.

What to watch next is whether the good-news pace of recovery translates into stable performance in subsequent outings. The best indicator will be how Skubal handles the usual post-surgery ramp-up issues: pitch command under stress, consistency of velocity and movement, and his ability to cover multiple innings without losing effectiveness. Detroit’s longer-term assignment is to keep that progress on course while balancing the day-to-day needs of the rest of its rotation and bullpen.